Regulatory Challenges in Pharmaceutical Technology addresses the complexities of navigating regulatory frameworks in the development and deployment of new pharmaceutical technologies. It covers compliance issues, approval processes, and the impact of evolving regulations on innovation. The book emphasizes strategies for overcoming regulatory hurdles to bring advanced pharmaceutical products to market. Suitable for pharmaceutical professionals and regulatory affairs specialists, it promotes understanding and management of regulatory challenges in pharma technology.
Layne Bowers specializes in navigating regulatory challenges within pharmaceutical technology, ensuring compliance and safety in drug development and manufacturing processes. Her research addresses the evolving regulatory landscape, focusing on the integration of new technologies such as AI and blockchain in pharmaceuticals. Layne has developed comprehensive frameworks that assist pharmaceutical companies in meeting regulatory requirements while innovating their technological approaches. She has authored numerous studies on the impact of regulatory policies on pharmaceutical innovation and market access. As an editor, Layne provides insightful guidelines for stakeholders to effectively manage regulatory challenges, promoting responsible and compliant advancements in pharmaceutical technology.